Difference between revisions of "MU Stage1 Final Rule - Electronically Exchange Prescription Information"

From VistApedia
Jump to: navigation, search
 
Line 50: Line 50:
 
See the drug interaction and allergy checking item 2 for a beginning to this discussion.
 
See the drug interaction and allergy checking item 2 for a beginning to this discussion.
  
'''DEVELOPMENT STATUS'''
+
'''DEVELOPMENT STATUS''' Speaking to the best of my knowledge (Nancy Anthracite), this is under development at Oroville hospital for eventual open source release. It will be required to subscribe to a service as multiple proprietary databases are involved whether or not ePrescribing is ever fully developed as a separate service exclusively for VistA as entirely open source software unless a convenient interface a totally free solution such as Allscripts is developed.  It is my understanging that Allscripts does not approve of screen scraping, etc. to make that interface possible so the use of the Oroville software seems to be the most reasonable solution.  The initial phase is in testing for release.  When Oroville will release it is in their court.  It will be necessary to use it or something else to achieve Meaningful Use to my knowledge as I don't know of any other group working on an open source solution.  We anticipate that the drug interaction that is supported by the national drug file will disappear as the VA moves to using FirstData, so the ePrescribing service or some alternative will be needed for that.  There is a potential for doing local drug interaction checking with the ePrescribing software which will be another powerful incentive to subscribe to the service.
(Add details here)
+
 
  
 
'''ACTION ITEMS / NEXT STEPS'''
 
'''ACTION ITEMS / NEXT STEPS'''

Revision as of 14:45, 3 September 2010

SECTION # Section 170.304(b)—Electronically Exchange Prescription Information

MU OBJECTIVE Generate and transmit permissible prescriptions electronically (eRx)

MU STAGE 1 MEASURE (EP only) More than 40% of all permissible prescriptions written by the EP are transmitted electronically using certified EHR technology

CERTIFICATION CRITERION Final Rule Text: §170.304(b). Electronic prescribing. Enable a user to electronically generate and transmit prescriptions and prescription-related information in accordance with: (1) The standard specified in §170.205(b)(1) or §170.205(b)(2); and (2) The standard specified in 170.207(d).

STANDARDS §170.205(b)(1) §170.205(b)(2) 170.207(d)

TEST CRITERIA # §170.304 (b) http://healthcare.nist.gov/docs/170.304.b_ExchangePrescriptionInformation_v1.0.pdf

USERS CORE / MENU SOLUTION DEVELOPERS STATUS
EP CORE Oroville In development

SOLUTION DESIGN / TECHNOLOGY (Add details here)

SOLUTION COMPONENTS (Add details here - Ex. KIDS patch, Delphi code, User guide, Web resources, Manual test script, etc)

DEPENDENCIES (Add details here)

COMMENTS / NOTES (Add details here)

PREVIOUS NOTES See the drug interaction and allergy checking item 2 for a beginning to this discussion.

DEVELOPMENT STATUS Speaking to the best of my knowledge (Nancy Anthracite), this is under development at Oroville hospital for eventual open source release. It will be required to subscribe to a service as multiple proprietary databases are involved whether or not ePrescribing is ever fully developed as a separate service exclusively for VistA as entirely open source software unless a convenient interface a totally free solution such as Allscripts is developed. It is my understanging that Allscripts does not approve of screen scraping, etc. to make that interface possible so the use of the Oroville software seems to be the most reasonable solution. The initial phase is in testing for release. When Oroville will release it is in their court. It will be necessary to use it or something else to achieve Meaningful Use to my knowledge as I don't know of any other group working on an open source solution. We anticipate that the drug interaction that is supported by the national drug file will disappear as the VA moves to using FirstData, so the ePrescribing service or some alternative will be needed for that. There is a potential for doing local drug interaction checking with the ePrescribing software which will be another powerful incentive to subscribe to the service.


ACTION ITEMS / NEXT STEPS (Add details here)

OPEN ISSUES / QUESTIONS (Add details here)